Paper33414404
Prostate apoptosis response-4 and tumor suppression: it's not just about apoptosis anymore.
Cheratta AR and 5 others. Cell Death Dis, 2021. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Prostate apoptosis response-4 and tumor suppression: it's not just about apoptosis anymore. Papers, record 33414404. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33414404
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prostate apoptosis response-4 and tumor suppression: it's not just about apoptosis anymore.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis Regulatory Proteins | Major topic |
| Genes, Tumor Suppressor | Major topic |
| Apoptosis | |
| Humans | |
| Signal Transduction |
Source PubMed
References138
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11742505 | Dlk/ZIP kinase-induced apoptosis in human medulloblastoma cells: requirement of the mitochondrial apoptosis pathway. | Br J Cancer | 2001 | https://conductscience.org/library/papers/11742505 | PubMed |
| 2 | 29278364 | TNF-α and IFN-γ Together Up-Regulates Par-4 Expression and Induce Apoptosis in Human Neuroblastomas. | Biomedicines | 2017 | https://conductscience.org/library/papers/29278364 | PubMed |
| 3 | 24418097 | Concomitant induction of apoptosis and autophagy by prostate apoptosis response-4 in hypopharyngeal carcinoma cells. | Am J Pathol | 2014 | https://conductscience.org/library/papers/24418097 | PubMed |
| 4 | 22552839 | Mechanisms of apoptosis by the tumor suppressor Par-4. | J Cell Physiol | 2012 | https://conductscience.org/library/papers/22552839 | PubMed |
| 5 | 16540633 | The phosphoinositide 3-kinase/Akt1/Par-4 axis: a cancer-selective therapeutic target. | Cancer Res | 2006 | https://conductscience.org/library/papers/16540633 | PubMed |
| 6 | 22532571 | Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). | J Biol Chem | 2012 | https://conductscience.org/library/papers/22532571 | PubMed |
| 7 | 20945400 | Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β. | J Cell Physiol | 2011 | https://conductscience.org/library/papers/20945400 | PubMed |
| 8 | 31195692 | TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31195692 | PubMed |
| 9 | 24795528 | Involvement of PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells to TRAIL-induced apoptosis. | Int J Biol Sci | 2014 | https://conductscience.org/library/papers/24795528 | PubMed |
| 10 | 16229834 | Par-4-mediated recruitment of Amida to the actin cytoskeleton leads to the induction of apoptosis. | Exp Cell Res | 2005 | https://conductscience.org/library/papers/16229834 | PubMed |
| 11 | 10597313 | Negative regulation of Par-4 by oncogenic Ras is essential for cellular transformation. | Oncogene | 1999 | https://conductscience.org/library/papers/10597313 | PubMed |
| 12 | 20433755 | Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network. | Mol Cancer | 2010 | https://conductscience.org/library/papers/20433755 | PubMed |
| 13 | 28187288 | Emerging Biological Principles of Metastasis. | Cell | 2017 | https://conductscience.org/library/papers/28187288 | PubMed |
| 14 | 27175591 | Post-translational regulation of the cleaved fragment of Par-4 in ovarian and endometrial cancer cells. | Oncotarget | 2016 | https://conductscience.org/library/papers/27175591 | PubMed |
| 15 | 29844124 | Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma. | Cancer Res | 2018 | https://conductscience.org/library/papers/29844124 | PubMed |
| 16 | 21328340 | TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells. | Int J Cancer | 2012 | https://conductscience.org/library/papers/21328340 | PubMed |
| 17 | 30987970 | Par-4 overexpression impedes leukemogenesis in the Eµ-TCL1 leukemia model through downregulation of NF-κB signaling. | Blood Adv | 2019 | https://conductscience.org/library/papers/30987970 | PubMed |
| 18 | 17332319 | Inactivation of the candidate tumor suppressor par-4 in endometrial cancer. | Cancer Res | 2007 | https://conductscience.org/library/papers/17332319 | PubMed |
| 19 | 28622290 | Structural basis for the regulatory interactions of proapoptotic Par-4. | Cell Death Differ | 2017 | https://conductscience.org/library/papers/28622290 | PubMed |
| 20 | 11585763 | Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression. | Cancer Res | 2001 | https://conductscience.org/library/papers/11585763 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42536224 | Par-4/TERT induced autophagy dysregulation in regulating glycolysis in hyperglycemia combined with hepatocellular carcinoma. | J Bioenerg Biomembr | 2026 | https://conductscience.org/library/papers/42536224 | PubMed |
| 42277020 | PAWR augments anti-RNA viral innate immunity by promoting the PIM2-XBP1s-RIG-I signaling axis. | Nat Commun | 2026 | https://conductscience.org/library/papers/42277020 | PubMed |
| 40831439 | An E. coli two-hybrid system to investigate human protein-protein interactions. | Biotechniques | 2025 | https://conductscience.org/library/papers/40831439 | PubMed |
| 40362431 | Transcriptome-Wide Analysis and Experimental Validation from FFPE Tissue Identifies Stage-Specific Gene Expression Profiles Differentiating Adenoma, Carcinoma In-Situ and Adenocarcinoma in Colorectal Cancer Progression. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40362431 | PubMed |
| 40143604 | Promotion of Autophagy and Apoptosis in Colorectal Cancer Exposed to Imatinib and Thymoquinone. | J Biochem Mol Toxicol | 2025 | https://conductscience.org/library/papers/40143604 | PubMed |
| 39273065 | The Tumor Suppressor Par-4 Regulates Adipogenesis by Transcriptional Repression of PPARγ. | Cells | 2024 | https://conductscience.org/library/papers/39273065 | PubMed |
| 38891847 | Anti-Cancer and Anti-Proliferative Potential of Cannabidiol: A Cellular and Molecular Perspective. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38891847 | PubMed |
| 38886572 | Tumor suppressor Par-4 activates autophagy-dependent ferroptosis. | Commun Biol | 2024 | https://conductscience.org/library/papers/38886572 | PubMed |
| 38672261 | Antitumor Efficacy of Arylquin 1 through Dose-Dependent Cytotoxicity, Apoptosis Induction, and Synergy with Radiotherapy in Glioblastoma Models. | Biomedicines | 2024 | https://conductscience.org/library/papers/38672261 | PubMed |
| 38093605 | Evidence of direct interaction between cisplatin and the caspase-cleaved prostate apoptosis response-4 tumor suppressor. | Protein Sci | 2024 | https://conductscience.org/library/papers/38093605 | PubMed |
| 37772386 | Differential response of MDA‑MB‑231 breast cancer and MCF10A normal breast cells to cytoskeletal disruption. | Oncol Rep | 2023 | https://conductscience.org/library/papers/37772386 | PubMed |
| 37432179 | The Antitumor Potential of λ-Carrageenan Oligosaccharides on Gastric Carcinoma by Immunomodulation. | Nutrients | 2023 | https://conductscience.org/library/papers/37432179 | PubMed |
| 37189414 | Enhancing the Conformational Stability of the cl-Par-4 Tumor Suppressor via Site-Directed Mutagenesis. | Biomolecules | 2023 | https://conductscience.org/library/papers/37189414 | PubMed |
| 35804970 | Prostate Apoptosis Response-4 (Par-4): A Novel Target in Pyronaridine-Induced Apoptosis in Glioblastoma (GBM) Cells. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35804970 | PubMed |
| 35615145 | ST08 Altered NF-κB Pathway in Breast Cancer Cells In Vitro as Revealed by miRNA-mRNA Analysis and Enhanced the Effect of Cisplatin on Tumour Reduction in EAC Mouse Model. | Front Oncol | 2022 | https://conductscience.org/library/papers/35615145 | PubMed |
| 34439262 | The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34439262 | PubMed |
| 34130596 | Epigenetic Editing in Prostate Cancer: Challenges and Opportunities. | Epigenetics | 2022 | https://conductscience.org/library/papers/34130596 | PubMed |
Genes22
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33414404
GET https://conductscience.org/api/papers/v1/33414404/references?page=2